Edition:
United Kingdom

Adverum Begins Patient Enrollment In Advance Phase 1/2 Clinical Trial


Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Adverum Biotechnologies Inc ::ADVERUM BIOTECHNOLOGIES BEGINS PATIENT ENROLLMENT IN THE ADVANCE PHASE 1/2 CLINICAL TRIAL FOR A1AT DEFICIENCY.ADVERUM BIOTECHNOLOGIES INC - ‍COMPANY EXPECTS TO REPORT PRELIMINARY DATA IN SECOND HALF OF 2018​. 

Company Quote

9.22
0.05 +0.55%
24 May 2019